TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
ELTX

Elicio Therapeutics Inc.

Healthcare · Biotechnology

1.80$ -2.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Elicio Therapeutics Inc. (ELTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -37 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ELTX
Line item 2012 2013 2018 2019 2020 2021 2022 2023 2024 2025
1.1 1.9 -8.0 -25 -23 -24 -22 -33 -37 -37
0.5 0.5 0.0 0.5 0.6 0.3 1.1 1.2 1.2 1.1
– – – 0.1 0.3 0.6 0.6 1.2 1.5 2.7
– – – 0.2 0.4 1.3 5.1 – – –
-0.1 0.3 3.1 9.8 26 0.9 -0.2 -0.1 4.0 -3.4
0.0 0.0 0.0 0.2 0.0 0.5 0.7 0.1 0.1 0.0
0.0 -0.1 – -0.2 0.0 -0.5 -0.7 0.0 -0.1 0.0
– – – -0.4 0.0 – 0.0 -0.2 -0.5 –
– – – 15 15 15 0.0 10 20 0.0
-0.4 -1.2 32 4.9 52 19 21 39 42 37
0.6 0.7 23 -20 29 -5.1 -81 5.9 5.2 -0.2
1.0 1.9 -8.0 -25 -23 -24 -23 -33 -37 -37

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?